Because, there is no research about the involvement of RAD9A hypermethylation, leukemia development and progression to date, we designed experiments with EBV, tumor cell lines, and bone marrow samples from leukemia patients to elucidate a possible mechanistic involvement. Here, RAD9A is linked to neoplasm.